Neurocrine Biosciences (NBIX) Selling, General & Administrative (2010 - 2026)
Neurocrine Biosciences' Selling, General & Administrative came in at $439.7 million for Q2 2026, up 53.6% from $286.3 million a year earlier and up 38.1% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Neurocrine Biosciences reported Selling, General & Administrative of $1.35 billion, up 24.6% year-over-year; for FY2025, it came in at $1.16 billion, up 14.8% from FY2024.
- Selling, General & Administrative has increased in each of the last 12 years, with a five-year compound annual growth rate of 21.7% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $1.01 billion in FY2024 (+13.5%), $887.6 million in FY2023 (+17.9%), $752.7 million in FY2022 (+29.0%) and $583.3 million in FY2021 (+34.6%).
- The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
- Year-over-year, Selling, General & Administrative has increased for 51 consecutive quarters, with growth averaging 22.0% over the last eight quarters.
- Across the past five years, year-over-year growth in Selling, General & Administrative ran from 0.2% in Q1 2024 to 55.6% in Q1 2022.
- Business Quant data shows NBIX's Selling, General & Administrative at $318.5 million (Q1 2026), $301.8 million (Q4 2025) and $291.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Neurocrine Biosciences | 14.55 Bn | 10.25 Bn | 935.80 Mn | 439.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 439.70 Mn |
| Mar 31, 2026 | 318.50 Mn |
| Dec 31, 2025 | 301.80 Mn |
| Sep 30, 2025 | 291.60 Mn |
| Jun 30, 2025 | 286.30 Mn |
| Mar 31, 2025 | 276.50 Mn |
| Dec 31, 2024 | 287.80 Mn |
| Sep 30, 2024 | 234.30 Mn |
| Jun 30, 2024 | 242.00 Mn |
| Mar 31, 2024 | 243.10 Mn |
| Dec 31, 2023 | 218.90 Mn |
| Sep 30, 2023 | 204.20 Mn |
| Jun 30, 2023 | 221.80 Mn |
| Mar 31, 2023 | 242.70 Mn |
| Dec 31, 2022 | 182.90 Mn |
| Sep 30, 2022 | 186.30 Mn |
| Jun 30, 2022 | 182.80 Mn |
| Mar 31, 2022 | 200.70 Mn |
| Dec 31, 2021 | 156.50 Mn |
| Sep 30, 2021 | 154.60 Mn |
API Access
Neurocrine Biosciences Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();